DiaMedica Therapeutics Inc. Share Price
NASDAQ: DMAC | Micro CapDiaMedica Therapeutics Inc. Stock Performance
Open $6.68 | Prev. Close $6.73 | Circuit Range N/A |
Day Range $6.36 - $6.68 | Year Range $5.16 - $10.36 | Volume 3,100 |
Average Traded $6.46 |
DiaMedica Therapeutics Inc. Share Price Today
As of 29 August 2026, DiaMedica Therapeutics Inc.'s share price is $6.38. The stock opened at $6.68, compared to its previous close of $6.73. During today's trading session, DiaMedica Therapeutics Inc.'s share price traded between $6.36 and $6.68, with an average price of $6.52. Over the past 52 weeks, the stock has recorded a high of $10.36 and a low of $5.16. In terms of performance, DiaMedica Therapeutics Inc.'s share price has declined by 19.58% over the last six months and is up 11.92% on a year-on-year basis.
DiaMedica Therapeutics Inc. Share Price Chart
DiaMedica Therapeutics Inc. Stock Fundamentals & Key Indicators
Market Cap $299.97M | PE Ratio (TTM) -9.12 | Dividend Yield N/A |
EPS (TTM) $-0.70 | Revenue (TTM) N/A | Return On Equity (TTM) -58.39% |
Profit Margin N/A | Debt to Equity 0.09 | Quarterly Earnings Growth YoY -37.39% |
DiaMedica Therapeutics Inc. Quarterly Profit & Loss
All figures in USD
DiaMedica Therapeutics Inc. Annual Profit & Loss
All figures in USD
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company also develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
DiaMedica Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $6.35 | $6.74 | +6.65% |
Jul 2026 | $7.14 | $6.32 | -10.61% |
Jun 2026 | $5.94 | $7.07 | +17.83% |
May 2026 | $5.93 | $6.00 | -0.50% |
Apr 2026 | $6.80 | $6.03 | -10.93% |
Mar 2026 | $7.82 | $6.77 | -14.74% |
Feb 2026 | $8.15 | $7.94 | -1.37% |
Jan 2026 | $7.81 | $8.05 | +1.00% |
Dec 2025 | $8.43 | $7.97 | -7.54% |
Nov 2025 | $7.06 | $8.62 | +22.27% |
Oct 2025 | $6.83 | $7.05 | +2.62% |
Sep 2025 | $5.67 | $6.87 | +20.42% |
DMAC Share Price FAQs
What is DiaMedica Therapeutics Inc. share price today?
What is the 52 week high and 52 week low of DiaMedica Therapeutics Inc. stock?
What is DMAC's market capitalisation today?
What is DMAC's net income for the last quarter?
What is the 5 year returns of DMAC?
What is the high & low stock price of DMAC today?
Can I buy DMAC shares in India?